ProQR Therapeutics NV operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares ProQR Therapeutics NV with three other
companies in this sector in the United States:
AC Immune SA
(2018
sales of $7.36 million
of which 100%
was Pharmaceutical),
Aptinyx Inc
($6.57 million
of which 100%
was Pharmaceutical), and
US Stem Cell Inc
($6.70 million
).
Sales Analysis.
Sales increased substantially in 2018:
ProQR Therapeutics NV reported sales of $6.79 million
for the
year ending
December of 2018.
This
represents
an
increase of 298.6%
versus 2017, when the company's sales were $1.70 million.